Impact of TR34/L98H, TR46/Y121F/T289A and TR53 Alterations in Azole-Resistant Aspergillus fumigatus on Sterol Composition and Modifications after In Vitro Exposure to Itraconazole and Voriconazole
- PMID: 35056552
- PMCID: PMC8778474
- DOI: 10.3390/microorganisms10010104
Impact of TR34/L98H, TR46/Y121F/T289A and TR53 Alterations in Azole-Resistant Aspergillus fumigatus on Sterol Composition and Modifications after In Vitro Exposure to Itraconazole and Voriconazole
Abstract
Background: Sterols are the main components of fungal membranes. Inhibiting their biosynthesis is the mode of action of azole antifungal drugs that are widely used to treat fungal disease including aspergillosis. Azole resistance has emerged as a matter of concern but little is known about sterols biosynthesis in azole resistant Aspergillus fumigatus.
Methods: We explored the sterol composition of 12 A. fumigatus isolates, including nine azole resistant isolates with TR34/L98H, TR46/Y121F/T289A or TR53 alterations in the cyp51A gene and its promoter conferring azole resistance. Modifications in sterol composition were also investigated after exposure to two azole drugs, itraconazole and voriconazole.
Results: Overall, under basal conditions, sterol compositions were qualitatively equivalent, whatever the alterations in the target of azole drugs with ergosterol as the main sterol detected. Azole exposure reduced ergosterol composition and the qualitative composition of sterols was similar in both susceptible and resistant isolates. Interestingly TR53 strains behaved differently than other strains.
Conclusions: Elucidating sterol composition in azole-susceptible and resistant isolates is of interest for a better understanding of the mechanism of action of these drugs and the mechanism of resistance of fungi.
Keywords: Aspergillus fumigatus; azole-resistance; ergosterol; sterol; tandem repeat.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.Antimicrob Agents Chemother. 2015 Nov 2;60(1):387-92. doi: 10.1128/AAC.02326-15. Print 2016 Jan. Antimicrob Agents Chemother. 2015. PMID: 26525787 Free PMC article.
-
Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands.J Antimicrob Chemother. 2015 Jan;70(1):178-81. doi: 10.1093/jac/dku364. Epub 2014 Oct 9. J Antimicrob Chemother. 2015. PMID: 25301884
-
First detection of TR46/Y121F/T289A and TR34/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environment.Antimicrob Agents Chemother. 2014 Sep;58(9):5096-101. doi: 10.1128/AAC.02855-14. Epub 2014 Jun 16. Antimicrob Agents Chemother. 2014. PMID: 24936595 Free PMC article.
-
Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.Dan Med J. 2016 Oct;63(10):B5288. Dan Med J. 2016. PMID: 27697142 Review.
-
Azole-resistant Aspergillus fumigatus in the environment: Identifying key reservoirs and hotspots of antifungal resistance.PLoS Pathog. 2021 Jul 29;17(7):e1009711. doi: 10.1371/journal.ppat.1009711. eCollection 2021 Jul. PLoS Pathog. 2021. PMID: 34324607 Free PMC article. Review.
Cited by
-
Fungal Sterol Analyses by Gas Chromatography-Mass Spectrometry Using Different Derivatives.Methods Mol Biol. 2023;2704:143-156. doi: 10.1007/978-1-0716-3385-4_8. Methods Mol Biol. 2023. PMID: 37642842
-
Regulation of Ergosterol Biosynthesis in Pathogenic Fungi: Opportunities for Therapeutic Development.Microorganisms. 2025 Apr 10;13(4):862. doi: 10.3390/microorganisms13040862. Microorganisms. 2025. PMID: 40284698 Free PMC article. Review.
-
Development and validation of next-generation sequencing-based clinical test for triazole resistance prediction in Aspergillus fumigatus.J Clin Microbiol. 2025 Aug 13;63(8):e0029125. doi: 10.1128/jcm.00291-25. Epub 2025 Jul 1. J Clin Microbiol. 2025. PMID: 40590562 Free PMC article.
References
-
- Ullmann A.J., Aguado J.M., Arikan-Akdagli S., Denning D.W., Groll A.H., Lagrou K., Lass-Flörl C., Lewis R.E., Munoz P.E., Verweij P.E., et al. Diagnosis and management of Aspergillus diseases: Executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin. Microbiol. Infect. 2018;24((Suppl. 1)):e1–e38. doi: 10.1016/j.cmi.2018.01.002. - DOI - PubMed
-
- Patterson T.F., Thompson G.R., Denning D., Fishman J.A., Hadley S., Herbrecht R., Kontoyiannis D.P., Marr K.A., Morrison V.A., Nguyen M.H., et al. Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin. Infect. Dis. 2016;63:433–442. doi: 10.1093/cid/ciw444. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources